These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 2370876)
1. Augmentation of tumor cell immunogenicity by viruses--an approach to specific immunotherapy of cancer. Shoham J; Hirsch R; Zakay-Rones Z; Osband ME; Brennert HJ Nat Immun Cell Growth Regul; 1990; 9(3):165-72. PubMed ID: 2370876 [TBL] [Abstract][Full Text] [Related]
2. Selective oncolytic effect of an attenuated Newcastle disease virus (NDV-HUJ) in lung tumors. Yaacov B; Eliahoo E; Lazar I; Ben-Shlomo M; Greenbaum I; Panet A; Zakay-Rones Z Cancer Gene Ther; 2008 Dec; 15(12):795-807. PubMed ID: 18535620 [TBL] [Abstract][Full Text] [Related]
3. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy. Merritt RE; Yamada RE; Crystal RG; Korst RJ J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342 [TBL] [Abstract][Full Text] [Related]
4. [Enhanced antitumor effects induced by lymphotactin gene-modified dendritic cells after pulsed with tumor antigen peptide]. Zhang W; He L; Cao X Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):170-3. PubMed ID: 11601032 [TBL] [Abstract][Full Text] [Related]
6. Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice. Gorelik E Cancer Res; 1987 Feb; 47(3):809-15. PubMed ID: 3802083 [TBL] [Abstract][Full Text] [Related]
7. Vascular attack by 5,6-dimethylxanthenone-4-acetic acid combined with B7.1 (CD80)-mediated immunotherapy overcomes immune resistance and leads to the eradication of large tumors and multiple tumor foci. Kanwar JR; Kanwar RK; Pandey S; Ching LM; Krissansen GW Cancer Res; 2001 Mar; 61(5):1948-56. PubMed ID: 11280751 [TBL] [Abstract][Full Text] [Related]
8. Induction of highly immunogenic variants of Lewis lung carcinoma tumor by ultraviolet irradiation. Peppoloni S; Herberman RB; Gorelik E Cancer Res; 1985 Jun; 45(6):2560-6. PubMed ID: 2580624 [TBL] [Abstract][Full Text] [Related]
9. Potent systemic antitumor activity from an oncolytic herpes simplex virus of syncytial phenotype. Fu X; Zhang X Cancer Res; 2002 Apr; 62(8):2306-12. PubMed ID: 11956088 [TBL] [Abstract][Full Text] [Related]
10. Induction of strong antitumor immunity by an HSV-2-based oncolytic virus in a murine mammary tumor model. Li H; Dutuor A; Fu X; Zhang X J Gene Med; 2007 Mar; 9(3):161-9. PubMed ID: 17266169 [TBL] [Abstract][Full Text] [Related]
11. Immuno-viral therapy of brain tumors by combination of viral therapy with cancer vaccination using a replication-conditional HSV. Toda M; Iizuka Y; Kawase T; Uyemura K; Kawakami Y Cancer Gene Ther; 2002 Apr; 9(4):356-64. PubMed ID: 11960286 [TBL] [Abstract][Full Text] [Related]
12. Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus. Schirrmacher V; Haas C; Bonifer R; Ahlert T; Gerhards R; Ertel C Gene Ther; 1999 Jan; 6(1):63-73. PubMed ID: 10341877 [TBL] [Abstract][Full Text] [Related]
13. B-cell depletion using an anti-CD20 antibody augments antitumor immune responses and immunotherapy in nonhematopoetic murine tumor models. Kim S; Fridlender ZG; Dunn R; Kehry MR; Kapoor V; Blouin A; Kaiser LR; Albelda SM J Immunother; 2008 Jun; 31(5):446-57. PubMed ID: 18463540 [TBL] [Abstract][Full Text] [Related]
14. Oncogenes-antioncogenes and virus therapy of cancer. Sinkovics JG Anticancer Res; 1989; 9(5):1281-90. PubMed ID: 2556069 [TBL] [Abstract][Full Text] [Related]
15. Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity. Cao X; Zhang W; He L; Xie Z; Ma S; Tao Q; Yu Y; Hamada H; Wang J J Immunol; 1998 Dec; 161(11):6238-44. PubMed ID: 9834111 [TBL] [Abstract][Full Text] [Related]
16. ICP34.5 deleted herpes simplex virus with enhanced oncolytic, immune stimulating, and anti-tumour properties. Liu BL; Robinson M; Han ZQ; Branston RH; English C; Reay P; McGrath Y; Thomas SK; Thornton M; Bullock P; Love CA; Coffin RS Gene Ther; 2003 Feb; 10(4):292-303. PubMed ID: 12595888 [TBL] [Abstract][Full Text] [Related]
17. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease. Hill HC; Conway TF; Sabel MS; Jong YS; Mathiowitz E; Bankert RB; Egilmez NK Cancer Res; 2002 Dec; 62(24):7254-63. PubMed ID: 12499267 [TBL] [Abstract][Full Text] [Related]